Vitamin D level and extent of coronary stenotic lesions in patients with first acute myocardial infarction by Goleniewska, Beata et al.
Address for correspondence: Beata Goleniewska, MD, Intensive Cardiac Therapy Clinic, Medical University of Lodz,  
ul. Sterlinga 1/3, 91–425 Łódź, Poland, tel/fax: +48 42 664 43 64, e-mail address: bgoleniewska@op.pl
Received: 24.02.2013 Accepted: 10.04.2013
ORIGINAL ARTICLE
Cardiology Journal 
2014, Vol. 21, No. 1, pp. 18–23
DOI: 10.5603/CJ.a2013.0048 
Copyright © 2014 Via Medica
ISSN 1897–5593
18 www.cardiologyjournal.org
Vitamin D level and extent of  
coronary stenotic lesions in patients with  
first acute myocardial infarction
Beata Goleniewska, Michał Kacprzak, Marzenna Zielińska
Intensive Cardiac Therapy Clinic, Medical University of Lodz, Lodz, Poland
Abstract
Background: The study aimed to examine the relationship between vitamin D levels and the 
extent of coronary stenotic lesions in patients with ST-segment elevation myocardial infarction 
(STEMI). Experimental evidence points to the involvement of multiple factors in coronary plaque 
formation, including vitamin D. Little is known, however, about the association of vitamin D  
level with the intensity of atherosclerosis.
Methods: Serum concentrations of 25-hydroxyvitamin D [25(OH)D] were measured in 130 
consecutive patients with the first acute STEMI treated with primary percutaneous coronary 
intervention. STEMI was the first symptom of coronary artery disease (CAD). The study popu-
lation was divided into patients with single and multi-vessel CAD. The angiographic severity 
of CAD was also determined based on the Gensini score.
Results: The median 25(OH)D concentration was 11.12 ng/mL (25th and 75th percentile: 
6.05; 17.12). Insufficient (20–30 ng/mL), deficient (10–20 ng/mL) and severely deficient  
(< 10 ng/mL) 25(OH)D levels were present in 18%, 35% and 45% of the individuals, re-
spectively. Only 2 (2%) of patients had proper 25(OH)D levels (> 30 ng/mL). The 25(OH)D 
concentrations between patients with single- and multi-vessel CAD did not differ significantly 
(10.2 vs. 11.4 ng/mL, p = 0.62). There was no significant correlation between 25(OH)D levels 
and Gensini score (r = –0.0221, p = 0.81).
Conclusions: The study demonstrated that vitamin D level is not associated with the severity 
of coronary lesions in patients with the first STEMI. A high prevalence of vitamin D deficiency 
in these patients was confirmed. (Cardiol J 2014; 21, 1: 18–23)
Key words: vitamin D, coronary angiogram, acute myocardial infarction,  
coronary artery disease
Introduction
Cardiovascular disease (CVD) remains the 
leading cause of death in the developed world. 
Atherosclerosis, the principal cause of myocardial 
infarction (MI) and cerebral infarction, accounts for 
the majority of these deaths. The pathogenesis of 
atherosclerosis has not yet been well elucidated. 
Experimental evidence points to the involvement 
of multiple factors in plaque formation, including 
vitamin D.
Vitamin D has an established role in calcium 
homeostasis, bone mineralization and regulation of 
parathyroid hormone secretion; accumulated kno-
wledge has further revealed a broad distribution of 
vitamin D receptors, that includes: cardiovascular, 
musculoskeletal, gastrointestinal, immune, central 
nervous system, endocrine organs and others [1]. 
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Hypovitaminosis D could participate in the patho-
genesis of several diseases. Epidemiological stu-
dies have demonstrated the independent associa-
tion between vitamin D deficiency and CVD risk 
factors, such as hypertension [2], diabetes mellitus 
[3], obesity [4], metabolic syndrome [5], subclinical 
atherosclerosis (intima-media thickness [IMT]) 
[6], and coronary calcification [7, 8]. Hypovitamino-
sis D has also been associated with cardiovascular 
events, such as MI [9], congestive heart failure, 
sudden cardiac death [10] and total mortality [11].
Vitamin D has potential ameliorating effects on 
the development of atherosclerosis by several me-
chanisms, but the molecular mechanisms of this as-
sociation remain not completely understood. Serum 
levels of vitamin D seem to be inversely associated 
with the extent of vascular calcifications, which are 
frequently found in patients with CVD. Vitamin 
could protect against atherosclerosis and vascular 
calcification by its inhibiting effect on vascular smo-
oth muscle cells proliferation. It directly or indirectly 
regulates the expression of a number of proteins 
relevant to the arterial wall, such as vascular endo-
thelial growth factor, matrix metalloproteinase type 
9, elastin, and type I collagen. Probably, vitamin D 
has also an impact on the cardiovascular system by 
exerting anticoagulant and antifibrotic activity [12], 
thereby preventing thrombosis.
Accumulated evidence indicates that athero-
sclerosis is an autoimmune disease [13]. Vitamin D 
could also be associated with CVD by down-
-regulating pro-inflammatory cytokines (tumor 
necrosis factor [TNF-a] and interleukin [IL-6]) and 
up-regulating anti-inflammatory cytokines (IL-10) 
[14–16]. The study revealed that a reduction in 
atherosclerotic lesion formation resulted from the 
suppression of immune reactions, with at least 
2 cell types crucially involved in vitamin D3 ef-
fects (regulatory T cells and dendritic cells) [17]. 
Because hypovitaminosis D is easily correctable, 
establishing the relationship between vitamin D 
and the risk of atherosclerosis is very important.
Little is known, however, about the association 
of vitamin D with the intensity of atherosclerosis. 
A few studies have focused on this problem in patients 
with acute coronary syndrome. The aim of the this 
study was therefore to determine both the vitamin D 
level and its association with the extent of coronary 
stenotic lesions in patients with acute MI.
Methods
Study population
The study involved a group of 130 consecutive 
patients, Caucasian in origin, aged > 18 years, 
and admitted to our hospital due to the first acu-
te ST-segment elevation MI (STEMI) treated 
with primary percutaneous coronary intervention 
(pPCI). STEMI was the first symptom of coronary 
artery disease (CAD). The study was performed 
within 2 years (2010–2011) during summer (June, 
July) and winter (November, December) months 
when there is the highest and lowest sun exposure.
Patients with a history of malignancy within 
the past 5 years, abnormal liver or renal function 
(serum aminotransferase activity > 40 IU/L, glo-
merular filtration rate [GFR] < 60 mL/min/1.72 m2), 
thyroid or parathyroid disease, sarcoidosis, tuber-
culosis, rickets type I, II, III, hypophosphatemic 
rickets, nephrotic syndrome, autoimmune disease, 
were excluded from the study.
Baseline characteristics were obtained for all 
patients. We recorded demographic information, 
cardiovascular history, risk factors (hypercholeste-
rolemia, smoking, hypertension and diabetes mel-
litus), and prior embolic events. Acute STEMI was 
defined according to consensus documents of the 
American College of Cardiology and the European 
Society of Cardiology [18]. Within 90 min of admis-
sion, all patients had coronary angiography with 
subsequent pPCI performed. Standard concomitant 
therapy (aspirin, thienopyridines, beta-blockers, 
ACE-inhibitors, statins) was administered in all 
eligible patients.
The angiographic severity of CAD was de-
termined based on the Gensini score [19]. The 
Gensini score was calculated for each patient from 
the coronary arteriogram by assigning a severity 
score to each coronary stenosis according to the 
degree of luminal narrowing and its geographic 
importance. Reduction in the lumen diameter, 
and the roentgenographic appearance of concen-
tric lesions and eccentric plaques were evaluated 
(reductions of 25%, 50%, 75%, 90%, 99%, and 
complete occlusion were given Gensini scores of 
1, 2, 4, 8, 16, and 32, respectively). Each principal 
vascular segment was assigned a multiplier in 
accordance with the functional significance of the 
myocardial area supplied by that segment: the left 
main coronary artery × 5; the proximal segment 
of left anterior descending coronary artery (LAD) 
× 2.5; the proximal segment of the circumflex 
artery × 2.5; the mid-segment of the LAD × 1.5; 
the right coronary artery, the distal segment of 
the LAD, the posterolateral artery and the obtuse 
marginal artery × 1; and others × 0.5.
Independently, the study population was di-
vided into patients with single and multi-vessel 
CAD. Angiographic single — and vessel CAD was 
defined as the occurrence of one critical stenosis 
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of at least 70% in a major coronary artery (anterior 
descending coronary artery, right coronary artery, 
circumflex coronary artery) estimated by visual 
analysis. By analogy, multi-vessel CAD was defined 
as the occurrence of more than one critical stenosis 
of at least 70% in a major coronary artery and/or 
of at least 50% in the left main coronary artery.
Serum concentrations of 25-hydroxyvitamin D 
[25(OH)D] were measured in the research labora-
tory using a electrochemiluminescence immuno-
assay method (ECLIA Roche diagnostics, Mann-
heim, Germany). Blood samples were obtained by 
venipuncture in the morning the day after coronary 
angiography and placed into tubes that were protec-
ted from sunlight. Serum was separated and stored 
at –70°C within 30 min of collection. Participants 
were classified into clinically-relevant categories 
on the basis of 25(OH)D levels. Patients with levels 
≥ 30 ng/mL were classified as normal, while levels 
> 20 ng/mL and < 30 ng/mL were considered 
insufficient. Levels of > 10 ng/mL to £ 20 ng/mL 
were deficient, and levels £ 10 ng/mL were se-
verely deficient, according to current clinical 
guidelines [20].
The study was approved by the local bioethical 
committee and all patients gave their informed 
consent.
Statistical analysis
Continuous variables were summarized by 
median values with corresponding 25th and 75th 
percentiles (Q25 and Q75). Discrete variables were 
summarized in terms of frequencies and percenta-
ges. Comparisons between groups were made using 
the Whitney-Mann test and Pearson’s c2 analysis for 
continuous and categorical variables, respectively. 
Correlations between continuous variables were 
determined by Spearman’s correlation coefficients. 
Multiple logistic regression analysis was used to 
identify independent predictors of multi-vessel 
CAD. P-value of < 0.05 was considered statistical-
ly significant. All analyses were performed using 
Statistica 10.0 (StatSoft Inc., USA).
Results
Clinical and biochemical characteristics of the 
group are shown in Table 1.
Table 1. Baseline characteristics of study population.
Single-vessel CAD (n = 65) Multi-vessel CAD (n = 65) P
Age [years] 58 [52; 67] 61.5 [56; 71] 0.06
Male 46 (70.8%) 43 (66.2%) 0.57
Body mass index [kg/m2] 25.9 [24.2; 34.1] 27.6 [25; 30.5] 0.42
Diabetes 10 (15.4%) 23 (35.4%) 0.009
Hypertension 32 (49.2%) 44 (67.7%) 0.03
Current smokers 42 (64.6%) 33 (50.8%) 0.10
Systolic BP [mm Hg] 130 [115; 150] 130 [110; 140] 0.72
Diastolic BP [mm Hg] 80 [70; 85] 80 [70; 80] 0.75
Total cholesterol [mmol/L] 5.2 [4.6; 5.9] 5.5 [4.4; 6.3] 0.36
HDL-C [mmol/L] 1.3 [1.1; 1.5] 1.3 [1.1; 1.5] 0.58
LDL-C [mmol/L] 3.2 [2.4; 3.6] 3.2 [2.4; 3.9] 0.51
Triglycerides [mmol/L] 1.4 [1.2; 2.1] 1.5 [1; 2.3] 0.80
25(OH)D [ng/mL] 10.2 [5.3; 16.7] 11.4 [6.3; 17.9] 0.62
Hs-CRP [mg/L] 4.0 [1.1; 15] 5.2 [2.2; 13.9] 0.37
Ejection fraction [%] 50 [45; 54] 49 [43; 55] 0.74
Final MI diagnosis:
Infero-posterior 30 (46.2%) 27 (41.5%) 0.6
Antero-lateral 35 (53.8%) 38 (58.5%) 0.6
Troponin T [ng/mL] 2.8 [0.7; 6] 2.9 [0.9; 5.3] 0.93
Gensini score 34 [32; 48] 66 [46; 86] 0.000001
Data are median [interquartile range] or numbers (percentages); CAD — coronary artery disease; BP — blood pressure; HDL-C — high density 
lipoprotein cholesterol; LDL-C — low density lipoprotein cholesterol; 25(OH)D — 25-hydroxyvitamin D; hs-CRP — high sensitivity C-reactive 
protein; MI — myocardial infarction
Figure 1. Distribution of vitamin D concentrations in 
patients with acute myocardial infarction; 25(OH)D — 
25-hydroksyvitamin D; sufficiency — 25(OH)D concen-
tration ≥ 30 ng/mL, deficiency — 25(OH)D concentra-
tion < 30 ng/mL.
Figure 2. 25-hydroksyvitamin D [25(OH)D] levels in pa-
tients with single- or multivessel coronary artery disease 
measured during summer and winter.
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Of the 130 enrolled patients, the median 
25(OH)D concentration was 11.12 ng/mL (25th 
and 75th percentile: 6.05; 17.12). Classification of 
25(OH)D levels into presented ranges showed 
59 (45%) patients to be severely deficient, 
45 (35%) to be deficient and 24 (18%) to be insuffi-
cient. Only 2 (2%) study participants had proper 
25(OH)D levels (Fig. 1). Low 25(OH)D levels were 
observed during both summer (June, July) and 
winter (November, December) months. However, 
in patients hospitalized in the summertime the 
25(OH)D concentration was slightly higher than 
in patients hospitalized in the wintertime (12.4; 
Q25 8.1; Q75 19.2 vs. 9.1; Q25 4.9; Q75 17.0 ng/mL; 
p = 0.034) (Fig. 2).
Single-vessel CAD was diagnosed in 65 (50%) 
patients. In our study we did not find any significant 
association between 25(OH)D concentrations and 
incidence of single and multi-vessel CAD. More 
often, patients with multi-vessel disease had 
diabetes and hypertension. Regarding body mass 
index (BMI), total cholesterol, HDL-cholesterol, 
LDL-cholesterol, triglycerides, calcium, intact pa-
rathyroid hormone, phosphate, creatinine, eGFR, 
high sensitivity C-reactive protein, there was no 
significant difference in those with single-vessel 
CAD or multi-vessel CAD.
The Gensini score ranged from 0 to 134 with 
a median of 48 (25th and 75th percentile: 32; 80).
There was no significant correlation between 
25(OH)D levels and Gensini score (r = –0.0221, 
p = 0.81; Fig. 3).
In the multiple stepwise logistic regression 
analysis of 25(OH)D level, demographic (age, 
sex) and clinical risk factors (BMI, diabetes, hy-
pertension, smoking status and total cholesterol 
concentration), diabetes revealed to be the only 
significant predictor of multi-vessel CAD (OR 1.9; 
95% CI 1.14–3.16; p = 0.013).
Figure 3. Correlation between vitamin D level and Gen-
sini score in patients with acute myocardial infarction; 
25(OH)D — 25-hydroksyvitamin D; r — Spearman’s rank 
correlation coefficient.
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Discussion
Our study describes the vitamin D status in 
patients presenting the first STEMI. It confirms 
a highly prevalent deficiency of vitamin D in these 
patients. Only 2% of participants had sufficient 
levels of 25(OH)D.
Lee et al. [21] have demonstrated similar re-
sults. Among 239 patients admitted with acute MI, 
96% had abnormal 25(OH)D levels (£ 30 ng/mL), 
75% were found to have 25(OH)D levels £ 20 ng/mL, 
which is in the deficient range, 24% were in the in-
sufficient range with vitamin D levels of 20 ng/mL to 
30 ng/mL and only 4% had normal level with vitamin 
D levels > 30 ng/mL. Mahdavi et al. [22] have also 
observed vitamin D deficiency in most patients with 
acute coronary syndrome. The proper 25(OH)D level 
was found only in 10.6% of 216 investigated patients 
(110 with STEMI, 106 with unstable angina/non-
-STEMI). Similar results were presented by Correia 
et al. [23]. Vitamin D sufficiency was diagnosed only in 
10% of 216 patients with acute MI (7% with STEMI). 
Serum 25(OH)D level < 20 ng/mL was present in 
59% of participants. The above studies support 
our observation of a high prevalence of vitamin D 
deficiency in patients with MI.
The relationship between vitamin D levels and 
atherosclerosis has been inconclusive. Vitamin D 
levels have been correlated with other measures 
of subclinical atherosclerosis. Among 390 patients 
with type 2 diabetes, vitamin D concentrations 
were inversely correlated with carotid IMT of the 
common carotid artery [6]. The results of another 
study presents an association between serum 
vitamin D levels and internal carotid, but not with 
common carotid IMT [24].
The results of 2 studies: The Multi-Ethnic 
Study of Atherosclerosis (MESA) [25] and The 
Coronary Artery Calcification in Type 1 Diabetes 
(CACTI) [26] indicate that vitamin D deficiency 
may be of particular importance during the early 
events leading to the development but not to the 
progression of coronary calcification. The results 
suggest that lower vitamin D levels predicted 
coronary artery calcification, which is a sensitive 
measure of subclinical coronary atherosclerosis 
and a strong risk factor for cardiovascular events.
In our study no statistically significant cor-
relation between 25(OH)D levels and severity 
of atherosclerosis in angiography was observed. 
There is a lack of data concerning this relationship 
in patients with STEMI. Although Correia et al. 
[23] in a comparable study have not evaluated the 
correlation between vitamin level and atheroscle-
rosis severity, they have noticed the same mean 
value of Gensini score in patients both with severe 
(< 10 ng/mL) and not severe (> 10 ng/mL) vitamin D 
deficiency. Similar observations were reported in 
LURIC study [10]. Serum 25(OH)D levels were 
measured in 3,299 Caucasian patients who were 
routinely referred to coronary angiography. Con-
cerning the vitamin level all patients were classified 
into four group (< 10, 10–20, 20–30, > 30 ng/mL). 
The frequency of angiographically defined CAD 
was similar in all groups.
As opposed to our results, Akin et al. [27] have 
described significant correlation between serum 
25(OH)D level and Gensini score measured in 
239 patients with CAD, who underwent coronary 
angiography. The relationship between vitamin D 
inadequacy and significant coronary artery stenosis 
was also found by Lim et al. [28]. The coronary arte-
ry calcium score and stenosis were evaluated using 
multidetector-row cardiac computed tomography.
On the basis of the results of the study we 
cannot determine whether levels greater than 
30 ng/mL would be associated with greater athero-
sclerosis reduction. Recently, the US-Institute of 
Medicine has declared circulating 25(OH)D levels 
of 30 ng/mL sufficient to the health of general 
population [29]. There is no doubt that future stu-
dies are needed to obtain a better clarification of 
the physiologic range of vitamin D for preventing 
atherosclerosis and CVD.
Limitations of the study
Blood samples were drawn only once in our 
cohort. A single 25(OH)D measurement may not 
reflect lifetime vitamin D status. Small study group 
limited power of some analyses, thus their results 
cannot be extrapolated to the general population 
of patients with STEMI.
Conclusions
In conclusion, this study demonstrates — to 
our knowledge for the first time — that level 
25(OH)D is not associated with the severity of 
coronary lesions on the angiogram of patients 
presenting with the first STEMI. We confirmed 
a high prevalence of vitamin D deficiency in pa-
tients with acute MI.
Acknowledgements
This study was supported by grant no. 
NN402504640 from the State Committee for 
Scientific Research, Poland.
Conflict of interest: none declared
www.cardiologyjournal.org 23
Beata Goleniewska et al., Vitamin D and coronary angiogram in patients with AMI
References
 1. DeLuca HF. Overview of general physiologic features and fun-
ctions of vitamin D. Am J Clin Nutr, 2004; 80: 1689–1696.
 2. Forman JP, Bischoff-Ferrari HA, Willett WC, Stampfer MJ, Curhan GC. 
Vitamin D intake and risk of incident hypertension: results from 
three large prospective cohort studies. Hypertension, 2005; 46: 
676–682.
 3. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D 
and calcium in type 2 diabetes. A systematic review and meta-
analysis. J Clin Endocrinol Metab, 2007; 92: 2017-2029.
 4. Lamendola CA, Ariel D, Feldman D, Reaven GM. Relations 
between obesity, insulin resistance, and 25-hydroxyvitamin D. 
Am J Clin Nutr, 2012; 95: 1055–1059. 
 5. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum 
vitamin D and the metabolic syndrome among U.S. adults. Diabe-
tes Care, 2005; 28:1228–1230.
 6. Targher G, Bertolini L, Padovani R et al. Serum 25-hydroxyvita-
min D3 concentrations and carotid artery intima-media thickness 
among type 2 diabetic patients. Clin Endocrinol (Oxf), 2006; 65: 
593–597.
 7. Watson KE, Abrolat ML, Malone LL et al. Active serum vitamin D 
levels are inversely correlated with coronary calcification. Circu-
lation, 1997; 96: 1755–1760.
 8. Zittermann A, Koerfer R. Protective and toxic effects of vitamin D 
on vascular calcification: clinical implications. Mol Aspects Med, 
2008; 29: 423–432.
 9. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D 
and risk of myocardial infarction in men: a prospective study. Arch 
Intern Med, 2008; 168: 1174–1180.
 10. Pilz S, März W, Wellnitz B et al. Association of vitamin D de-
ficiency with heart failure and sudden cardiac death in a large 
cross-sectional study of patients referred for coronary angiogra-
phy. J Clin Endocrinol Metab, 2008; 93: 3927–3935. 
 11. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin 
D levels and the risk of mortality in the general population. Arch 
Intern Med, 2008; 168: 1629–1637.
 12. Aihara K, Azuma H, Akaike M et al. Disruption of nuclear vitamin D 
receptor gene causes enhanced thrombogenicity in mice. J Biol 
Chem, 2004; 279: 35798–35802.
 13. Nilsson J, Hansson GK. Autoimmunity in atherosclerosis: 
A protective response losing control? J Intern Med, 2008; 263: 
464–478.
 14. Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Net-
work on Atherothrombosis. Inflammation in atherosclerosis: 
From pathophysiology to practice. J Am Coll Cardiol, 2009; 54: 
2129–2138.
 15. Klingenberg R, Hansson GK. Treating inflammation in athero-
sclerotic cardiovascular disease: emerging therapies. Eur Heart J, 
2009; 30: 2838–2844. 
 16. Lavie CJ, Milani RV, Verma A, O’Keefe JH. C-reactive protein and 
cardiovascular diseases: Is it ready for primetime? Am J Med Sci, 
2009; 338: 486–492.
 17. Takeda M, Yamashita T, Sasaki N et al. Oral administration of an 
active form of vitamin D3 (calcitriol) decreases atherosclerosis in 
mice by inducing regulatory T cells and immature dendritic cells 
with tolerogenic functions. Arterioscler Thromb Vasc Biol, 2010; 
30: 2495–2503.
 18. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF 
Task Force for the Redefinition of Myocardial Infarction. Uni-
versal definition of myocardial infarction. Eur Heart J, 2007; 28: 
2525–2538.
 19. Gensini GG. A more meaningful scoring system for determining 
the severity of coronary heart disease. Am J Cardiol, 1983; 51: 606.
 20. Holick MF, Binkley NC, Bischoff-Ferrari HA et al. Evaluation, 
treatment, and prevention of vitamin D deficiency: An Endocrine 
Society clinical practice guideline J Clin Endocrinol Metab, 2011; 
96: 1911–1930.
 21. Lee JH, Gadi R, Spertus JA, Tang F, O’Keefe JH. Prevalence of 
vitamin D deficiency in patients with acute myocardial infarction. 
Am J Cardiol, 2011; 107: 1636–1638.
 22. Mahdavi K, Amirajam Z, Yazdankhah S et al. The prevalence 
and prognostic role of vitamin d deficiency in patients with acute 
coronary syndrome: A single centre study in South-West of Iran. 
Heart Lung Circ, 2012; doi: 10.1016/j.hlc.2012.11.006. 
 23. Correia L, Sodré F, Garcia G et al. Relation of severe deficiency 
of vitamin D to cardiovascular mortality during acute coronary 
syndromes. Am J Cardiol, 2013; 111: 324–327.
 24. Reis JP, von Mühlen D, Michos ED et al. Serum vitamin D, para-
thyroid hormone levels, and carotid atherosclerosis. Atheroscle-
rosis, 2009; 207: 585–590.
 25. de Boer IH, Kestenbaum B, Shoben AB, Michos ED, Sarnak MJ, 
Siscovick DS. 25-hydroxyvitamin D levels inversely associate 
with risk for developing coronary artery calcification. J Am Soc 
Nephrol, 2009; 20: 1805–1812.
 26. Young KA, Snell-Bergeon JK, Naik RG et al. Vitamin D deficiency 
and coronary artery calcification in subjects with type 1 diabetes. 
Diabetes Care, 2011; 34: 454–458.
 27. Akin F, Ayca B, Kose N et al. Serum vitamin D levels are inde-
pendently associated with severity of coronary artery disease. 
J Investig Med, 2012; 60: 869–873.
 28. Lim S, Shin H, Kim MJ et al. Vitamin D inadequacy is associated 
with significant coronary artery stenosis in a community-based 
elderly cohort: The Korean Longitudinal Study on Health and 
Aging. J Clin Endocrinol Metab, 2012; 97: 169–178.
 29. Ross AC, Taylor CL, Yaktine AL, Del Valle HB eds. Institute 
of Medicine (US) Committee to Review Dietary Reference In-
takes for Vitamin D and Calcium. Dietary reference intakes for 
calcium and vitamin D. National Academies Press (US), Washing-
ton 2011: 370.
